glatiramer: profile and news

Long-Term Copaxone(R) Study Showed 92% Of Multiple Sclerosis ...  May 9, 2006
...study showed that 92 percent of relapsing-remitting multiple sclerosis (RRMS) patients in the study who remained on COPAXONE(R) (glatiramer acetate injection ... - Medical News Today (press release),

Multiple Sclerosis: New Insights and Trends  May 10, 2006
...beta-interferon-la (Avonex), subcutaneous beta-interferon-1a (Rebif), subcutaneous beta-interferon-1b (Betaseron), and glatiramer acetate (Copaxone). ... - AJNR (subscription),

Two MS drugs better than one?  Apr 17, 2006
National Institutes of Health, the study will determine if the combined use of Avonex (interferon beta-1a) once a week and Copaxone (glatiramer acetate) daily ... - myDNA.com,

PharmaFrontiers Gets $23M To Advance MS Compound  Apr 17, 2006
...given as a one-hour infusion every month, while Avonex (interferon beta-1a), also from Biogen Idec, is dosed weekly, and Copaxone (glatiramer acetate), from ... - BioWorld Online (subscription),